Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Treasury Shares: 2017-2023

Historic Treasury Shares for Dianthus Therapeutics (DNTH) over the last 1 years, with Sep 2023 value amounting to $63.

  • Dianthus Therapeutics' Treasury Shares was N/A to $63 in Q3 2023 from the same period last year, while for Sep 2023 it was $63, marking a year-over-year change of. This contributed to the annual value of $16,084 for FY2022, which is N/A change from last year.
  • Per Dianthus Therapeutics' latest filing, its Treasury Shares stood at $63 for Q3 2023, which was down 99.61% from $16,084 recorded in Q4 2022.
  • In the past 5 years, Dianthus Therapeutics' Treasury Shares registered a high of $205,722 during Q4 2019, and its lowest value of $63 during Q3 2023.
  • Over the past 2 years, Dianthus Therapeutics' median Treasury Shares value was $8,074 (recorded in 2022), while the average stood at $8,074.
  • Data for Dianthus Therapeutics' Treasury Shares shows a maximum YoY tumbled of 79.88% (in 2019) over the last 5 years.
  • Dianthus Therapeutics' Treasury Shares (Quarterly) stood at $205,722 in 2019, then followed by $16,084 in 2022, then followed by $63 in 2023.
  • Its Treasury Shares stands at $63 for Q3 2023, versus $16,084 for Q4 2022 and $205,722 for Q4 2019.